Francesca Orlandi

845 total citations
31 papers, 655 citations indexed

About

Francesca Orlandi is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Francesca Orlandi has authored 31 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Francesca Orlandi's work include Peptidase Inhibition and Analysis (7 papers), Immunotherapy and Immune Responses (7 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Francesca Orlandi is often cited by papers focused on Peptidase Inhibition and Analysis (7 papers), Immunotherapy and Immune Responses (7 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Francesca Orlandi collaborates with scholars based in Italy, United States and France. Francesca Orlandi's co-authors include Jedd D. Wolchok, Alan N. Houghton, Polly D. Gregor, Simone U. Dalm, Marion de Jong, Berthold A. Nock, C. Leung, Θεοδοσία Μάινα, D. Craft and Philip J. Bergman and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Clinical Cancer Research.

In The Last Decade

Francesca Orlandi

29 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Orlandi Italy 15 281 197 192 183 167 31 655
Sangeetha M. Reddy United States 15 499 1.8× 79 0.4× 256 1.3× 248 1.4× 77 0.5× 29 830
Robert E. Reeves United States 13 223 0.8× 182 0.9× 302 1.6× 140 0.8× 88 0.5× 14 800
M. Krémer France 13 144 0.5× 372 1.9× 137 0.7× 72 0.4× 95 0.6× 29 616
Gary Li United States 13 197 0.7× 128 0.6× 355 1.8× 136 0.7× 69 0.4× 32 702
Daniela Ludwig Germany 8 124 0.4× 90 0.5× 407 2.1× 98 0.5× 77 0.5× 15 632
Zohar Mishal France 16 104 0.4× 54 0.3× 209 1.1× 287 1.6× 100 0.6× 28 677
Ang Cui United States 12 416 1.5× 61 0.3× 435 2.3× 377 2.1× 59 0.4× 24 1.1k
Payel Bhanja United States 12 202 0.7× 296 1.5× 339 1.8× 96 0.5× 46 0.3× 25 782
Evgeny S. Egorov Russia 9 112 0.4× 81 0.4× 314 1.6× 444 2.4× 77 0.5× 10 726
Renelle J. Gee United States 16 108 0.4× 242 1.2× 292 1.5× 539 2.9× 41 0.2× 21 939

Countries citing papers authored by Francesca Orlandi

Since Specialization
Citations

This map shows the geographic impact of Francesca Orlandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Orlandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Orlandi more than expected).

Fields of papers citing papers by Francesca Orlandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Orlandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Orlandi. The network helps show where Francesca Orlandi may publish in the future.

Co-authorship network of co-authors of Francesca Orlandi

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Orlandi. A scholar is included among the top collaborators of Francesca Orlandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Orlandi. Francesca Orlandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Basaia, Silvia, Francesca Orlandi, Elisa Canu, et al.. (2025). Glymphatic Dysfunction in Clinical Phenotypes of Motor Neuron Disease (S5.009). Neurology. 104(7_Supplement_1).
2.
Cecchetti, Giordano, Francesca Orlandi, Edoardo Gioele Spinelli, et al.. (2025). Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases. Journal of Neurology. 272(2). 168–168.
3.
Orlandi, Francesca, Arenn F. Carlos, Farwa Ali, et al.. (2024). Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants. Brain Communications. 6(2). fcae113–fcae113. 3 indexed citations
4.
Cecchetti, Giordano, Federica Agosta, Edoardo Gioele Spinelli, et al.. (2024). Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer’s disease: a real-world study. Journal of Neurology. 271(10). 6739–6749. 9 indexed citations
5.
Haeck, Joost, et al.. (2023). The Balance Between the Therapeutic Efficacy and Safety of [177Lu]Lu-NeoB in a Preclinical Prostate Cancer Model. Molecular Imaging and Biology. 26(1). 114–123. 7 indexed citations
6.
Laliscia, Concetta, Angiolo Gadducci, Francesca Orlandi, et al.. (2021). MRI-based radiomics: promise for locally advanced cervical cancer treated with a tailored integrated therapeutic approach. Tumori Journal. 108(4). 376–385. 14 indexed citations
7.
Gruber, Leonhard, Luis David Jiménez‐Franco, Clemens Decristoforo, et al.. (2020). MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of 68Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients. Journal of Nuclear Medicine. 61(12). 1749–1755. 46 indexed citations
8.
Summer, Dominik, Claudia Manzl, Christine Rangger, et al.. (2016). Targeting Gastrointestinal Stromal Tumor with 68 Ga-Labeled Peptides: An In Vitro Study on Gastrointestinal Stromal Tumor-Cell Lines. Cancer Biotherapy and Radiopharmaceuticals. 31(8). 302–310. 12 indexed citations
9.
Garrigue, Philippe, Guillaume Hache, Youssef Bennis, et al.. (2016). Erythropoietin Pretreatment of Transplanted Endothelial Colony-Forming Cells Enhances Recovery in a Cerebral Ischemia Model by Increasing Their Homing Ability: A SPECT/CT Study. Journal of Nuclear Medicine. 57(11). 1798–1804. 22 indexed citations
10.
Delishaj, D., Agata Rembielak, Bruno Manfredi, et al.. (2016). Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature. Journal of Contemporary Brachytherapy. 6(6). 533–540. 56 indexed citations
11.
Dalm, Simone U., Erik de Blois, Gabriela N. Doeswijk, et al.. (2016). 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology. Journal of Nuclear Medicine. 58(2). 293–299. 103 indexed citations
12.
Guandalini, Luca, Lorenzo Di Cesare Mannelli, Gianluca Bartolucci, et al.. (2015). Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235. Bioorganic & Medicinal Chemistry Letters. 25(8). 1700–1704. 14 indexed citations
13.
Orlandi, Francesca, Marcella Coronnello, Cristina Bellucci, et al.. (2012). New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR). Bioorganic & Medicinal Chemistry. 21(2). 456–465. 15 indexed citations
14.
Orlandi, Francesca, José A. Guevara-Patiño, Taha Merghoub, et al.. (2011). Combination of epitope-optimized DNA vaccination and passive infusion of monoclonal antibody against HER2/neu leads to breast tumor regression in mice. Vaccine. 29(20). 3646–3654. 12 indexed citations
15.
Yuan, Jianda, Francesca Orlandi, Humilidad F. Gallardo, et al.. (2009). Cytokine changes in castrate metastatic prostate cancer (CPMC) patients (pts) treated with ipilimumab (Ipi). Journal of Clinical Oncology. 27(15_suppl). e16149–e16149. 1 indexed citations
16.
Orlandi, Francesca, Franco Maria Venanzi, Antonio Concetti, et al.. (2007). Antibody and CD8+ T Cell Responses against HER2/neu Required for Tumor Eradication after DNA Immunization with a Flt-3 Ligand Fusion Vaccine. Clinical Cancer Research. 13(20). 6195–6203. 20 indexed citations
17.
Engelhorn, Manuel E., Da Young Song, Polly D. Gregor, et al.. (2007). Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes. Vaccine. 25(29). 5330–5342. 19 indexed citations
18.
Gregor, Polly D., Jedd D. Wolchok, Francesca Orlandi, et al.. (2006). Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma.. PubMed. 6. 8–8. 100 indexed citations
19.
Gregor, Polly D., Francesca Orlandi, D. Craft, et al.. (2005). Xenogeneic Human Tyrosinase DNA Vaccination Induces Specific Immune Response in Dogs with Advanced Malignant Melanoma. Veterinary and Comparative Oncology. 3(1). 48–48. 1 indexed citations
20.
Orlandi, Francesca, et al.. (2002). Molecular Stability of DNA Typing Short Tandem Repeats in the Mammary Tree of Patients with Breast Cancer. Diagnostic Molecular Pathology. 11(1). 41–46. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026